President of the Spanish Government and minister of Health and Social Policy met with representatives from the Spanish Association for the Pharmaceutical Industry (Farmaindustria).
They have recently closed distribution deals with companies from the medical sectors in these two countries. Avinent’s turnover in 2009 totaled 4.2 million euros and is expected to reach 6 million euros by the end of this year.
Anna Vila, director of Advancell Nanosystems Division: "It is in a key location, searching for continuous exchange of knowledge and resources between university and company".
Intelligent Pharma, Neurotec Pharma, SOM Biotech, Palo Biofarma and the Barcelona Science Park have decided to create a research consortium to join forces and technology to design new multiple sclerosis (MS) therapies.
Neogenius Pharma is an innovative project of its kind in the Spanish pharmaceutical industry and a clear example of public-private cooperation to foster R&D&I.
Over the next three years, they will carry out a number of projects to support the start up of new companies in the life sciences field, identify new private investors and attract international investors.
It is a company dedicated to nutraceutics development, pharmacogenetics solutions and research in innovative treatments for lung cancer. The company generates an income of 2,1 million euros.
